When discussing the dangers of smoking, most people think of lung cancer, heart disease, and respiratory illness. However, smoking has wide-ranging effects that extend to every part of the body—including the prostate. The prostate is a small gland in the male reproductive system, yet it plays an essential role in urinary and sexual function. At 1Prostate Center, located in Manhattan and Queens and led by Dr. David Shusterman, patients are increasingly asking about lifestyle factors that impact prostate health. Smoking, as it turns out, is a significant contributor to both prostate disease and reduced treatment outcomes, especially in older men.
Increased Risk of Prostate Cancer
Smoking has been associated with several types of cancer, and the prostate is no exception. Although early studies showed mixed results, more recent and comprehensive research has linked smoking with a higher risk of aggressive prostate cancer. The carcinogens found in tobacco smoke don’t just remain in the lungs—they circulate through the bloodstream, exposing every organ to their harmful effects. These toxins may contribute to the development of cancerous cells within the prostate or worsen preexisting conditions.
Notably, smoking is associated with more advanced stages of prostate cancer at diagnosis and poorer prognoses. Men who smoke are more likely to have high-grade tumors, meaning the cancer is more aggressive and fast-growing. Additionally, smokers face a higher risk of cancer recurrence after treatment, including surgery or radiation therapy. This suggests that smoking doesn’t just influence whether prostate cancer develops—it also impacts how it behaves and how effectively it can be treated.
Reduced Effectiveness of Prostate Cancer Treatment
For men undergoing treatment for prostate cancer, smoking presents additional challenges. It can reduce the body’s ability to heal after surgery, increase the risk of complications, and interfere with the success of radiation or hormone therapy. Some studies show that smokers are more likely to experience side effects from radiation treatment and have lower survival rates following a prostate cancer diagnosis.
Smoking affects oxygen delivery throughout the body, including to tissues that are recovering after prostatectomy or radiation. Poor circulation can delay wound healing and increase the likelihood of infections or long-term scarring. In men receiving hormone therapy, smoking may also blunt the therapy’s effectiveness, making it harder to control the growth of cancer cells. This compounding effect makes smoking one of the most significant modifiable factors influencing prostate cancer outcomes.
Inflammation and Prostatitis Risk
Chronic inflammation is believed to play a role in the development and progression of many prostate disorders. Smoking contributes to systemic inflammation, which can impact the prostate and increase the risk of conditions such as prostatitis. Prostatitis, or inflammation of the prostate gland, can be acute or chronic and may result in pelvic pain, painful urination, and sexual dysfunction.
The toxic chemicals in tobacco can irritate tissues throughout the urinary and reproductive systems, triggering immune responses that lead to localized swelling and discomfort. In chronic cases, this inflammation may persist even in the absence of infection, making symptoms difficult to manage. Men who smoke may be more likely to experience recurrent or resistant forms of prostatitis, as smoking weakens immune function and limits the body’s ability to resolve inflammation efficiently.
Effects on Hormones and Testosterone Levels
The relationship between smoking and hormone balance is complex, but growing evidence suggests that tobacco use may negatively impact male reproductive hormones. Some studies indicate that smokers may have elevated levels of certain hormones like dihydrotestosterone (DHT), which is associated with prostate growth and enlargement. At the same time, smoking may also contribute to reduced total testosterone, which can influence libido, muscle mass, and mood.
The alteration of hormonal levels may have multiple consequences for prostate health. For example, an imbalance in DHT could promote the development of benign prostatic hyperplasia (BPH), a non-cancerous enlargement of the prostate that causes urinary issues. Meanwhile, lower testosterone may indirectly affect prostate function and reduce the overall resilience of reproductive tissues. These hormonal shifts may help explain why smokers are more likely to report a range of prostate-related concerns.
Impact on Urinary Function
One of the most noticeable effects of prostate problems is difficulty with urination. Men may experience a weak stream, urgency, frequency, or a sensation of incomplete emptying. While these symptoms are commonly linked to BPH or prostatitis, smoking can exacerbate them. The chemicals in tobacco are known to irritate the bladder and urethra, contributing to urinary tract dysfunction.
Smoking may also increase the likelihood of developing bladder infections or bladder cancer, both of which can cause overlapping urinary symptoms. In smokers with existing prostate enlargement, even minor bladder irritation can amplify discomfort and disrupt daily routines. Furthermore, nicotine acts as a stimulant, which can cause the bladder to contract more frequently and unpredictably, worsening symptoms like nocturia (frequent nighttime urination).
Erectile Dysfunction and Sexual Health
Prostate health is closely tied to sexual function, and smoking is a well-documented risk factor for erectile dysfunction (ED). Poor circulation caused by smoking limits blood flow to the penis, making it difficult to achieve or maintain an erection. For men already dealing with prostate conditions, adding smoking to the mix may further diminish quality of life by compounding both urinary and sexual difficulties.
Beyond circulation, smoking can impair nerve function and lead to vascular damage that affects the pelvic region. Over time, this damage reduces sensitivity and responsiveness, interfering with sexual performance. Prostate conditions like prostatitis or post-treatment recovery from cancer can already strain sexual health, so maintaining optimal blood flow and nerve function is crucial. Smoking directly undermines these systems, making recovery more difficult and symptoms more persistent.
Potential Benefits of Quitting Smoking
While the consequences of smoking are serious, the good news is that quitting can produce substantial benefits—even for men who have smoked for many years. Smoking cessation is associated with reduced inflammation, improved circulation, and enhanced immune function. These improvements can support prostate healing, increase the effectiveness of cancer treatments, and improve long-term health outcomes.
Within a few weeks of quitting, blood pressure begins to normalize, and oxygen levels improve. Over time, the risk of heart disease, stroke, and many cancers decreases. For the prostate specifically, men who stop smoking may reduce their chances of aggressive cancer, lower the risk of recurrence after treatment, and improve urinary function. These gains are even more significant when combined with other healthy lifestyle changes such as a balanced diet, regular physical activity, and appropriate medical screenings.
Takeaway for Men in Manhattan and Queens
Smoking is a powerful factor in many aspects of health, but its impact on the prostate is often underestimated. From increasing the risk of aggressive prostate cancer to worsening inflammation, urinary symptoms, and sexual dysfunction, tobacco use undermines male health at multiple levels. For men in Manhattan and Queens seeking to protect their prostate health, quitting smoking is one of the most impactful decisions they can make. Recognizing the connection between smoking and prostate disorders is a crucial first step toward prevention, early intervention, and improved outcomes over the long term.
Resources
Giovannucci, E., Liu, Y., Platz, E. A., Stampfer, M. J., & Willett, W. C. (2007). Risk Factors for Prostate Cancer Incidence and Progression in the Health Professionals Follow-up Study. International Journal of Cancer.
Shiels, M. S., Albanes, D., Wright, M. E., et al. (2009). Cigarette Smoking and Prostate Cancer Mortality: 26-Year Follow-Up of the NIH-AARP Diet and Health Study. Journal of the National Cancer Institute.
Huncharek, M., Haddock, K. S., Reid, R., & Kupelnick, B. (2010). Smoking as a Risk Factor for Prostate Cancer: A Meta-analysis of 24 Prospective Cohort Studies. American Journal of Public Health.
